Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Modified natural cycle (procedure)
• Programmed cycle (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of California San Francisco
  San Francisco, California, United States
  Site recruitment: Not reported
• Stanford University
  Sunnyvale, California, United States
  Site recruitment: Not reported
• Yale
  Orange, Connecticut, United States
  Site recruitment: Not reported
• Fertility Institute of Hawaii
  Honolulu, Hawaii, United States
  Site recruitment: Not reported
• Northwestern University
  Chicago, Illinois, United States
  Site recruitment: Not reported
• Johns Hopkins
  Baltimore, Maryland, United States
  Site recruitment: Not reported
• Shady Grove Fertility
  Rockville, Maryland, United States
  Site recruitment: Not reported
• Boston IVF
  Waltham, Massachusetts, United States
  Site recruitment: Not reported
• University of Rochester
  Rochester, New York, United States
  Site recruitment: Not reported
• Atrium Health
  Charlotte, North Carolina, United States
  Site recruitment: Not reported
• Cleveland Clinic Foundation
  Beachwood, Ohio, United States
  Site recruitment: Not reported
• University of Oklahoma
  Oklahoma City, Oklahoma, United States
  Site recruitment: Not reported
• University of Pennsylvania
  Philadelphia, Pennsylvania, United States
  Site recruitment: Not reported
• CARE Fertility
  Bedford, Texas, United States
  Site recruitment: Not reported
• West Virginia University Center for Reproductive Medicine
  Morgantown, West Virginia, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Urinary-hCG (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Akureyri Hospital
  Akureyri, Iceland
  Site recruitment: Not reported
• University of Akureyri
  Akureyri, Iceland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human chorionic gonadotropin (hCG) (drug)
• Prednisone (drug)
• Dexamethasone (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Universidad Autónoma de Nuevo León
  Monterrey, Nuevo León, Mexico
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Estradiol + Progesterone (drug)
• Ovitrelle ( Hcg 250 mcg) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Laura Burunat
  Barcelona, Spain, Spain
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin alpha (drug) — also listed as: Gonal F, Puregon, Urofollitropin
• Menotropin (drug) — also listed as: Menopur

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Poznan University of Medical Sciences
  Poznan, Poland
  Site recruitment: Not reported
• Reproductive Medicine Center
  Malmö, Sweden
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human chorionic gonadotropin (drug) — also listed as: HCG

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GnRH-a (drug)
• GnRH-anta (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Reproductive Medical Center, 1st Affiliated Hospital of Zhengzhou University
  Zhengzhou, Henan, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Assuit University, Assuit, Egypt.
  Asyut, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Elagolix 200 MG (drug)
• Leuprolide Acetate 3.75 MG/ML (drug)
• Lab work (diagnostic_test)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Colorado Center for Reproductive Medicine
  Lone Tree, Colorado, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Clomiphene Citrate. (drug) — also listed as: Clomid®
• Sildenafil Citrate (drug) — also listed as: Viagra®
• Intrauterine Insemination (procedure) — also listed as: IUI

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Batterjee Medical College
  Jeddah, Mecca Region, Saudi Arabia
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• FET Protocol (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Reproductive Medicine Associates of New Jersey
  Basking Ridge, New Jersey, United States
  Site recruitment: Not reported
• Reproductive Medicine Associates of New Jersey
  Marlton, New Jersey, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin beta injection 150 IU (drug) — also listed as: FOLLISTIM AQ
• Follitropin beta injection 300 IU (drug) — also listed as: FOLLISTIM AQ

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ART Fertility Clinics LLC
  Abu Dhabi, United Arab Emirates
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Estradiol Tablets (drug)
• Progesterone (drug)
• Follitropin Alfa (drug)
• Chorionic Gonadotropin, Alpha (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Herlev University Hospital
  Herlev, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human chorionic gonadotropin (drug) — also listed as: hCG

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Growth and Reproduction, Rigshospitalet
  Copenhagen, Denmark
  Site recruitment: Not reported
• Rigshospitalet
  Copenhagen, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG + estradiol (drug)
• Observation arm (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Assiut university
  Asyut, Asyut Governorate, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• corifollitropin alfa (drug) — also listed as: Org 36286, MK-8962, SCH 900962
• recombinant Follicle Stimulating Hormone (recFSH) (biological)
• human Chorion Gonadotropin (hCG) (biological)
• hCG Bolus injection (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Corifollitropin alpha (MK-8962, Org 36286) 100 ug (drug)
• Corifollitropin alpha (MK-8962, Org 36286) 150 ug (drug)
• Triptorelin (drug)
• Recombinant follicle stimulating hormone (recFSH) (biological)
• Human chorionic gonadotprophin (hCG). (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Corifollitropin alfa (biological) — also listed as: Org 36286, SCH 900962, MK-8962
• GnRH antagonist (biological)
• (rec)hCG (biological)
• FSH (biological)
• Progesterone (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human chorionic gonadotropin (drug) — also listed as: Home ovulation test
• Home ovulation test (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Tampere University Hospital
  Tampere, Finland
  Site recruitment: Not reported